Cargando…
Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483985/ https://www.ncbi.nlm.nih.gov/pubmed/31024014 http://dx.doi.org/10.1038/s41598-019-42459-5 |
_version_ | 1783414043364556800 |
---|---|
author | Shankaranarayanan, Jayanth Suryanarayanan Kanwar, Jagat R. AL-Juhaishi, Afrah Jalil Abd Kanwar, Rupinder K. |
author_facet | Shankaranarayanan, Jayanth Suryanarayanan Kanwar, Jagat R. AL-Juhaishi, Afrah Jalil Abd Kanwar, Rupinder K. |
author_sort | Shankaranarayanan, Jayanth Suryanarayanan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6483985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64839852019-05-07 Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice Shankaranarayanan, Jayanth Suryanarayanan Kanwar, Jagat R. AL-Juhaishi, Afrah Jalil Abd Kanwar, Rupinder K. Sci Rep Author Correction Nature Publishing Group UK 2019-04-25 /pmc/articles/PMC6483985/ /pubmed/31024014 http://dx.doi.org/10.1038/s41598-019-42459-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Author Correction Shankaranarayanan, Jayanth Suryanarayanan Kanwar, Jagat R. AL-Juhaishi, Afrah Jalil Abd Kanwar, Rupinder K. Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title | Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title_full | Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title_fullStr | Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title_full_unstemmed | Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title_short | Author Correction: Doxorubicin Conjugated to Immunomodulatory Anticancer Lactoferrin Displays Improved Cytotoxicity Overcoming Prostate Cancer Chemo resistance and Inhibits Tumour Development in TRAMP Mice |
title_sort | author correction: doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in tramp mice |
topic | Author Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483985/ https://www.ncbi.nlm.nih.gov/pubmed/31024014 http://dx.doi.org/10.1038/s41598-019-42459-5 |
work_keys_str_mv | AT shankaranarayananjayanthsuryanarayanan authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice AT kanwarjagatr authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice AT aljuhaishiafrahjalilabd authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice AT kanwarrupinderk authorcorrectiondoxorubicinconjugatedtoimmunomodulatoryanticancerlactoferrindisplaysimprovedcytotoxicityovercomingprostatecancerchemoresistanceandinhibitstumourdevelopmentintrampmice |